Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07243015

Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers

Sponsor: City of Hope Medical Center

View on ClinicalTrials.gov

Summary

Gastric cancer (GC) is a leading cause of cancer-related death worldwide. Even in patients undergoing curative surgery for non-metastatic disease, postoperative recurrence frequently occurs due to undetected minimal residual disease (MRD). This study aims to establish a highly sensitive and specific liquid biopsy assay using exosomal microRNAs (exo-miRNAs) to detect MRD and predict distant metastasis before clinical recurrence.

Official title: Exosomal microRNA-based Analysis for Early detectIon of Gastric Cancer Hidden-recurrence Traces

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2025-01-15

Completion Date

2026-06-18

Last Updated

2025-11-21

Healthy Volunteers

No

Conditions

Interventions

DIAGNOSTIC_TEST

small RNA-seq or array

small RNA-seq or array

DIAGNOSTIC_TEST

ENLIGHT Assay

RT-qPCR-based exo-miRNA quantification

Locations (1)

City of Hope Medical Center

Duarte, California, United States